Rocket Pharmaceuticals

This American #HeartMonth, #TeamRocket joins NHLBI – Heart Research & Education to raise awareness about #HeartDisease. We're committed to advancing #GeneTherapy research for inherited heart diseases, including #DanonDisease, PKP2-arrhythmogenic cardiomyopathy (#ACM), and BAG3-associated dilated cardiomyopathy (#DCM).    * Genetic testing is key to early diagnosis of rare cardiovascular conditions. Our Mission: Genome program helps families navigate this journey. Learn more: https://lnkd.in/g7Uv-dpJ    * Exciting progress in #DanonDisease: The Natural History Study we sponsor is now enrolling female patients, a critical step in understanding disease progression. Learn more: https://lnkd.in/gdNScFDq 

Join us on Tuesday, February 25, for Rocket Pharma’s #RareDiseaseDay 2025 event—an in-person and virtual gathering dedicated to raising awareness, amplifying patient voices, and advancing the conversation around #RareDiseases.    This year’s agenda features discussions on the evolving landscape of #DanonDisease, the power of #GeneticTesting in rare disease diagnosis, and the collaborative efforts needed to drive innovation and access to treatments. Patients, families, advocates, researchers, and industry leaders will come together to share perspectives and insights that shape the future of rare disease care.    Explore the full agenda and how to join here: https://lnkd.in/gwFxMX_n   #LightUpForRare #PatientAdvocacy 

#TeamRocket is pleased to launch our 2025 Summer Internship Program! Positions for the program span seven departments: Legal, Process Development, Analytical Development, Commercial, Facilities, Supply Chain/CMC Project Management and Finance. Each department offers a wide array of learning opportunities for oncoming interns.   We’re excited to continue our pursuit of identifying, nurturing, and elevating future gene therapy leaders who will progress our mission for generations to come.   Interested in applying? Learn more about the program and apply here: https://lnkd.in/dhqd7W-3   #Internship #SummerInternship #Hiring #GeneTherapy

#TeamRocket is proud to sponsor the American College of Cardiology Alabama Chapter’s Winter Conference. Stop by our booth to see how we’re advancing our #AAV #GeneTherapy cardiovascular pipeline of potentially curative treatment options for patients with high unmet needs and create a future where #DNAIsNoLongerDestiny. Learn more: https://lnkd.in/eQ9S32mg.

#TeamRocket was thrilled to sponsor the San Diego Heart Failure Winter Symposium. Special thanks to Dr. Barry Greenberg and the team at UC San Diego Health for planning another engaging event aimed at driving advances in recognizing and treating #HeartFailure. We also extend our gratitude to Dr. Kimberly Hong for her insightful contributions as a speaker at the symposium. Our team of innovators is hard at work advancing our #AAV #GeneTherapy cardiovascular pipeline of potentially curative treatment options for patients with high unmet needs. Learn more: https://lnkd.in/gFTGzUKd. #SDHF2025

#TeamRocket believes in fostering an environment where all ideas are welcome and the opinion of every team member is valued. We recently asked Sanchali Kasbekar, Pharm.D., R.Ph, Associate Vice President of Regulatory Affairs, to share what motivates her to support Rocket’s mission of seeking #GeneTherapy cures, and here’s what she said. To learn more about Rocket and our people driven by passion, creativity, and commitment to patients, click here: https://lnkd.in/exrgX9Pj.

#TeamRocket is thrilled to be participating in #JPM25!   Gaurav Shah, MD, CEO, gave an engaging company presentation, and our team is enjoying connecting with global industry leaders and members of the investment community in San Francisco.   Our team looks forward to a productive year ahead as we seek #GeneTherapy cures for patients with rare and devastating diseases. #JPMHC25

On January 13, #TeamRocket’s President, Head of R&D, and COO, Kinnari Patel, PharmD, MBA, will join fellow innovators in a panel discussion at the Alliance for Regenerative Medicine's Cell & Gene State of the Industry Briefing (#CGSOTI25). The panel will highlight future inflection points for cell and #GeneTherapies in the coming year and feature Whitney Ijem, Jim Birchenough MD, Lynelle Hoch, and Keith Crandell. Learn more: https://lnkd.in/gU_sJjg.

#TeamRocket’s President, Head of R&D, and COO, Kinnari Patel, PharmD, MBA, will participate in the Longwood Healthcare Leaders San Francisco CEO forum’s "Driving Productivity in R&D" panel discussion. Kinnari will join fellow industry leaders Nenad Grmusa, Chris Loose, Richard Wilson, and Joel Schneider to share insights on our journey driving innovation in #GeneTherapy to bring potentially curative treatment options to patients affected by rare and life-threatening diseases. Learn more: https://lnkd.in/esNkzCWY. #LongwoodHealthcareLeaders #SanFranciscoCEO

We’re starting the new year strong; #TeamRocket is thrilled to be headed to the West Coast for the 43rd annual J.P. Morgan Healthcare Conference – the largest healthcare investment symposium of the year. We look forward to previewing plans for the year ahead and connecting with industry leaders as we seek #GeneTherapy cures for patients with rare and devastating diseases. To learn more about our participation at #JPM25, please click here: https://lnkd.in/eargWDwY. #InvestorRelations #InvestorConference #HealthcareConference